Six-year follow-up of i-FACTOR® peptide enhanced bone graft vs autograft in single level ACDF in a randomized single blinded FDA investigational device exemption study

Publication/Presentation Date

2021

Volume

21

Issue

9

First Page

203

Last Page

203

Document Type

Article

Share

COinS